These results reinforced the notion that PHC ameliorated rI/R-induced lung inflammation by inhibiting the NF-κB pathway in a Nrf2-independent manner and by suppressing the NLRP3 pathway in a Nrf2-dependent manner. The gene discussed is NLRP3; the disease is inflammation.